
Direxion Daily TSLA Bull 2X Shares, Merck & Co., Inc., Pfizer, Exxon Mobil, Texas Instruments, Bristol Myers Squibb, and Comcast are the seven Dividend stocks to watch today, according to MarketBeat’s stock screener tool. Dividend stocks are shares of companies that regularly return a portion of their profits to shareholders as cash payments (dividends), often on a quarterly basis. Investors often buy them for income and potential lower volatility compared with non‑dividend stocks, though dividend levels can change and are not guaranteed. A common way to compare them is dividend yield, the annual dividends per share divided by the current share price. These companies had the highest dollar trading volume of any Dividend stocks within the last several days.
Direxion Daily TSLA Bull 2X Shares (TSLL)
Read Our Latest Research Report on TSLL
Merck & Co., Inc. (MRK)
Read Our Latest Research Report on MRK
Pfizer (PFE)
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands.
Read Our Latest Research Report on PFE
Exxon Mobil (XOM)
Exxon Mobil Corporation engages in the exploration and production of crude oil and natural gas in the United States and internationally. It operates through Upstream, Energy Products, Chemical Products, and Specialty Products segments. The Upstream segment explores for and produces crude oil and natural gas.
Read Our Latest Research Report on XOM
Texas Instruments (TXN)
Texas Instruments Incorporated designs, manufactures, and sells semiconductors to electronics designers and manufacturers in the United States and internationally. The company operates through Analog and Embedded Processing segments. The Analog segment offers power products to manage power requirements across various voltage levels, including battery-management solutions, DC/DC switching regulators, AC/DC and isolated controllers and converters, power switches, linear regulators, voltage references, and lighting products.
Read Our Latest Research Report on TXN
Bristol Myers Squibb (BMY)
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia.
Read Our Latest Research Report on BMY
Comcast (CMCSA)
Comcast Corporation operates as a media and technology company worldwide. It operates through Residential Connectivity & Platforms, Business Services Connectivity, Media, Studios, and Theme Parks segments. The Residential Connectivity & Platforms segment provides residential broadband and wireless connectivity services, residential and business video services, sky-branded entertainment television networks, and advertising.
Read Our Latest Research Report on CMCSA
Recommended Stories
- MarketBeat’s Top Five Stocks to Own in December 2025
- Insiders Buy Natural Gas Stocks: 2 for the Watchlist
- Rivian’s Autonomy Bombshell Changes Everything—Even Its Valuation
- Financial Sector Breaks Out as Capital Rotates and Leadership Shifts
- Super Micro’s Sell-Off Is a Mirage—Here’s Why the Rally May Come Back Fast
- 3 Companies Turning Big Cash Flow Into Bigger Shareholder Gains
